// App-Quantinova.ai

: Inpatient Mortality and Length of Stay Among Direct-Acting Oral Anticoagulant (DOAC) and Warfarin Users Presenting with Major Hemorrhage

Researchers

Presenter

  • Walter Bialkowski

Principal Investigators

  • Sylvia Tan

  • Alan E. Mast

  • Joseph Kiss

  • Daryl J. Kor

  • Jerome Gottschall

  • Yanyun Wu

  • Nareg H. Roubinian

  • Darrell Triulzi

  • Steven Kleinman

  • Young Choi

  • Donald Brambilla

  • Ann Butler Zimrin

Medical Centers

  • Blood Research and Medical Sciences Institutes, BloodCenter of Wisconsin, Germantown, WI

  • RRD International, Rockville, MD

  • Blood Center of Wisconsin, Milwaukee, WI

  • Institute for Transfusion Medicine, Pittsburgh, PA

  • Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN

  • Blood Ctr. of Southeastern WI, Milwaukee, WI

  • Yale Univ Schl of Med, New Haven, CT

  • University of California, San Francisco, San Francisco, CA

  • Institute for Transfusion Medicine, Pittsburgh, PA

  • University of British Columbia, Victoria, Canada

  • Yale School of Medicine, Yale University, New Haven, CT

  • University of Maryland Greenebaum Cancer Center, Baltimore, MD

  • National Heart, Lung and Blood Institute, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Renal insufficiency

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • apixaban

  • Edoxaban

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved